$0.396
0.002[0.51%]
At close: May 8
$0.396
0[0.00%]
PreMarket: 7:07PM EDT
BioCardia
(NASDAQ:BCDA)Latest News for BioCardia Stock (NASDAQ:BCDA)
BioCardia Stock (NASDAQ: BCDA)
Categories: All
Wednesday, May 01, 2024
- BioCardia Announced The Primary Endpoint Results Of The Open Label Roll-in Cohort Of The Cardiamp Cell Therapy In Chronic Myocardial Ischemia TrialBenzinga Newsdesk - May 1, 2024, 7:16AM
- BioCardia Announces Results From Open Label Roll-In Cohort Of Patients Having Chronic Myocardial Ischemia With Refractory Angina; Showed Avg. Increase In Exercise Tolerance Of 107 Seconds And An Avg. Of 82% Reduction In Angina Episodes At The Primary Six-Month Follow-Up EndpointBenzinga Newsdesk - May 1, 2024, 7:15AM
Thursday, April 25, 2024
Monday, April 22, 2024
Friday, March 29, 2024
Wednesday, March 27, 2024
- BioCardia: Q4 Earnings InsightsBenzinga Insights - Mar 27, 2024, 4:10PM
- BioCardia Q4 EPS $(0.09) Beats $(0.11) Estimate, Sales $13.00K Miss $90.00K EstimateBenzinga Newsdesk - Mar 27, 2024, 4:06PM
- BioCardia Ended 2023 With Cash And Cash Equivalents Of $1.1MBenzinga Newsdesk - Mar 27, 2024, 2:04PM
- Earnings Scheduled For March 27, 2024Benzinga Insights - Mar 27, 2024, 5:02AM
Tuesday, March 26, 2024
Wednesday, March 13, 2024
Tuesday, March 12, 2024
- BioCardia shares are trading higher after the company announced CMS approval of reimbursement coverage of the CardiAMP cell therapy Phase III heart failure study.Benzinga Newsdesk - Mar 12, 2024, 7:06AM
- BioCardia Announces CMS Approval Of Coverage Of The CardiAMP Cell Therapy Confirmatory Phase III Heart Failure StudyBenzinga Newsdesk - Mar 12, 2024, 7:04AM
Monday, March 04, 2024
- Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike HigherAvi Kapoor - Mar 4, 2024, 2:34PM
- Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Mar 4, 2024, 1:29PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Mar 4, 2024, 12:34PM
- Gold Gains 1%; JOANN Shares PlummetAvi Kapoor - Mar 4, 2024, 12:05PM
- BioCardia shares are trading lower amid volatility after the company announced interim results from its Phase III CardiAMP cell therapy heart failure trial.Benzinga Newsdesk - Mar 4, 2024, 11:45AM
- BioCardia Reports Interim Results From Phase III CardiAMP Cell Therapy Heart Failure Trial; Says 'Results showed reductions in heart death equivalents and MACCE, with a magnified reduction among patients with elevated NTproBNP, a common marker of heart distress'Benzinga Newsdesk - Mar 4, 2024, 8:03AM
Thursday, February 08, 2024
Friday, January 19, 2024
Monday, December 18, 2023
Tuesday, December 05, 2023
Wednesday, November 29, 2023
Friday, November 17, 2023
Thursday, November 16, 2023
Wednesday, November 15, 2023
Tuesday, November 14, 2023
- Dow Jumps Over 500 Points; Home Depot Earnings Top ViewsLisa Levin - Nov 14, 2023, 3:10PM
- Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Nov 14, 2023, 2:05PM
- BioCardia shares are trading higher after the company announced the FDA approved its Phase 3 clinical trial of its CardiAMP autologous cell therapy for the treatment of patients with ischemic heart failure.Benzinga Newsdesk - Nov 14, 2023, 1:36PM
- Crude Oil Moves Higher; Beauty Health Shares PlungeLisa Levin - Nov 14, 2023, 1:11PM
- HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price TargetBenzinga Newsdesk - Nov 14, 2023, 11:22AM
- 200% Gain In One Day - Why Is Heart Failure Focused BioCardia Stock Soaring Today?Vandana Singh - Nov 14, 2023, 11:05AM
- Nasdaq Surges 2%; US Inflation Rate Slows In OctoberLisa Levin - Nov 14, 2023, 9:50AM
- Market-Moving News for November 14thBenzinga Newsdesk - Nov 14, 2023, 8:41AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Nov 14, 2023, 8:06AM
- Biocardia Announced The FDA Approval Of Its Phase 3 Clinical Trial Of Its CardiAMP Autologous Cell Therapy For The Treatment Of Patients With Ischemic Heart FailureBenzinga Newsdesk - Nov 14, 2023, 7:18AM
Wednesday, November 08, 2023
Tuesday, November 07, 2023
Friday, October 20, 2023
Wednesday, October 11, 2023
- Where BioCardia Stands With AnalystsBenzinga Insights - Oct 11, 2023, 3:00PM
- HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price TargetBenzinga Newsdesk - Oct 11, 2023, 12:35PM
- BioCardia Announces Completion Of Enrollment In Phase III CardiAMP HF Trial And Plans For CardiAMP HF Trial IIBenzinga Newsdesk - Oct 11, 2023, 6:02AM